Patrick Caron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patrick Caron has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Chantal Guillemette
Faculty of Pharmacy, Université Laval, Québec, Canada
3 shared publications - Louis Lacombe
Research Centre of CHU de Québec-Université Laval, Québec City, Québec, Canada
3 shared publications - Cylia Dahmani
Centre de recherche du Centre Hospitalier Universitaire de Québec—Université Laval (CHU de Québec Research Centre—UL), Centre de recherche en cancer (CRC) de l’Université Laval and Faculty of Pharmacy, Université Laval, Quebec City, Quebec, Canada
2 shared publications - David Simonyan
CHU de Québec‐Université Laval Research Center Quebec City Quebec Canada
2 shared publications - Eric Lévesque
Centre de recherche sur le cancer (CRC) de l'Université Laval, Québec, Québec, Canada; Centre de recherche du Centre Hospitalier Universitaire de Québec - Université Laval (CRCHUQc-UL), Québec, Québec, Canada; Faculty of Medicine, Université Laval, Québec, Québec, Canada
2 shared publications - Fred Saad
University of Montreal
2 shared publications
Latest Publications
- Open Access
- 25 August 2025
- Published by MDPI AG in Preprints.org
Hepatic and Biliary Glucuronidation of Bisphenol A in Mice: A Reaction Catalyzed by the UDP-Glucuronosyltransferase (Ugt2b)1 and Ugt2b34 Enzymes
Bisphenol A (BPA) is an important industrial chemical used in the manufacture of polycarbonate plastic and epoxy resin-based products. This endocrine disruptor molecule is metabolized and eliminated primarily as a monoglucuronide. The purpose of this study was to identify those of murine tissues and UDP-glucuronosyltransferase (UGT) enzymes involved in BPA-glucuronide (-G) formation. A series of in vitro glucuronidation assays were performed using homogenates or microsomal fractions from murine tissues or HEK293 cells expressing each of the 7 murine Ugt2b isoforms. From the 29 tissues tested, the most reactive were the liver, gallbladder, caecum and colon. A low BPA-G formation was also detected in the ileum, oviduct and testis. KM values ranged from 19.6±7.5 (gallbladder) to 85.8±16.0µM (caecum), while with 190.3µL/min/mg proteins the gallbladder exhibited the highest intrinsic clearance value. From the 7 murine Ugt2bs, the highest BPA-G formation rates were obtained with the Ugt2b1 and Ugt2b34 isoforms. These 2 enzymes displayed important differences in terms of kinetic parameters: Ugt2b1 exhibited lower KM and Vmaxapp. values (2.5±0.2µM and 389.4±79.0pmol/min/mg proteins, respectively) than Ug2b34 (KM=98.4±3.3µM and Vmaxapp.=9,681.3±1,507.3pmol/min/mg proteins). However, CLINT. values revealed that both enzymes exhibit similar BPA glucuronidation efficiencies. Quantitative RT-PCR experiments further revealed that the profile of the Ugt2b34 mRNA expression correlates with BPA-G formation in tissues of the gastro-intestinal tract. In conclusion, the present study identifies tissues of the hepato-biliary-intestinal tract as well as the Ugt2b1 and Ugt2b34 isoforms as major contributors for bisphenol A glucuronidation in mice Surprisingly, gallbladder was very reactive with this substrate.
- 25 August 2025
- Published by MDPI AG in Preprints.org
Open AccessHepatic and Biliary Glucuronidation of Bisphenol A in Mice: A Reaction Catalyzed by the UDP-Glucuronosyltransferase (Ugt2b)1 and Ugt2b34 Enzymes
Bisphenol A (BPA) is an important industrial chemical used in the manufacture of polycarbonate plastic and epoxy resin-based products. This endocrine disruptor molecule is metabolized and eliminated primarily as a monoglucuronide. The purpose of this study was to identify those of murine tissues and UDP-glucuronosyltransferase (UGT) enzymes involved in BPA-glucuronide (-G) formation. A series of in vitro glucuronidation assays were performed using homogenates or microsomal fractions from murine tissues or HEK293 cells expressing each of the 7 murine Ugt2b isoforms. From the 29 tissues tested, the most reactive were the liver, gallbladder, caecum and colon. A low BPA-G formation was also detected in the ileum, oviduct and testis. KM values ranged from 19.6±7.5 (gallbladder) to 85.8±16.0µM (caecum), while with 190.3µL/min/mg proteins the gallbladder exhibited the highest intrinsic clearance value. From the 7 murine Ugt2bs, the highest BPA-G formation rates were obtained with the Ugt2b1 and Ugt2b34 isoforms. These 2 enzymes displayed important differences in terms of kinetic parameters: Ugt2b1 exhibited lower KM and Vmaxapp. values (2.5±0.2µM and 389.4±79.0pmol/min/mg proteins, respectively) than Ug2b34 (KM=98.4±3.3µM and Vmaxapp.=9,681.3±1,507.3pmol/min/mg proteins). However, CLINT. values revealed that both enzymes exhibit similar BPA glucuronidation efficiencies. Quantitative RT-PCR experiments further revealed that the profile of the Ugt2b34 mRNA expression correlates with BPA-G formation in tissues of the gastro-intestinal tract. In conclusion, the present study identifies tissues of the hepato-biliary-intestinal tract as well as the Ugt2b1 and Ugt2b34 isoforms as major contributors for bisphenol A glucuronidation in mice Surprisingly, gallbladder was very reactive with this substrate.
- Open Access
- 1 March 2025
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 213 (3) , 283-294
High 11-Ketotestosterone Linked to Shorter Time to Castration Resistance in Recurrent Nonmetastatic Prostate Cancer
The contribution of 11-oxygenated androgens to the progression of lethal prostate cancer (PCa) remains unresolved. We hypothesized that evaluating circulating levels of 11-oxygenated androgens, such as the androgen receptor agonist 11-ketotestosterone (11KT), could serve as a potential predictor of the onset of castration resistant prostate cancer (CRPC). We used mass spectrometry to quantify 11-oxygenated androgens in post-operative plasma samples acquired from 145 patients who subsequently received androgen deprivation therapy (ADT) for biochemical recurrence (BCR) and achieved castrated testosterone (T) levels. Kaplan-Meier survival analyses and multivariable Cox models were used to investigate relationships between steroids and CRPC. Of 145 patients, 31 developed CRPC with a median time to CRPC of 57 months. 11-oxygenated androgens levels were unaffected by ADT, which stands in contrast to the observed changes in T and other steroids. 11KT was the most abundant androgen but was not linked to clinical features. Kaplan-Meier analysis revealed that 11KT levels above the median of 273 pg/mL were associated with a shorter time to CRPC (P = 0.03). In multivariable analyses, this was supported with an adjusted hazard ratio of 2.17 (95% confidence interval (CI) 0.99-4.71; P = 0.05). 11KT is a key component of the hormonal profile predictive of earlier onset of CRPC. Enhancing our understanding of the specific role of 11KT in the progression to CRPC could help optimize hormonal therapy for castration sensitive PCa and CRPC patients.
- 1 March 2025
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 213 (3) , 283-294
Open AccessHigh 11-Ketotestosterone Linked to Shorter Time to Castration Resistance in Recurrent Nonmetastatic Prostate Cancer
The contribution of 11-oxygenated androgens to the progression of lethal prostate cancer (PCa) remains unresolved. We hypothesized that evaluating circulating levels of 11-oxygenated androgens, such as the androgen receptor agonist 11-ketotestosterone (11KT), could serve as a potential predictor of the onset of castration resistant prostate cancer (CRPC). We used mass spectrometry to quantify 11-oxygenated androgens in post-operative plasma samples acquired from 145 patients who subsequently received androgen deprivation therapy (ADT) for biochemical recurrence (BCR) and achieved castrated testosterone (T) levels. Kaplan-Meier survival analyses and multivariable Cox models were used to investigate relationships between steroids and CRPC. Of 145 patients, 31 developed CRPC with a median time to CRPC of 57 months. 11-oxygenated androgens levels were unaffected by ADT, which stands in contrast to the observed changes in T and other steroids. 11KT was the most abundant androgen but was not linked to clinical features. Kaplan-Meier analysis revealed that 11KT levels above the median of 273 pg/mL were associated with a shorter time to CRPC (P = 0.03). In multivariable analyses, this was supported with an adjusted hazard ratio of 2.17 (95% confidence interval (CI) 0.99-4.71; P = 0.05). 11KT is a key component of the hormonal profile predictive of earlier onset of CRPC. Enhancing our understanding of the specific role of 11KT in the progression to CRPC could help optimize hormonal therapy for castration sensitive PCa and CRPC patients.
- Open Access
- 1 February 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 209 (2) , 337-346
Preoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer
Purpose:Adrenal 11-oxygenated androgens may support cancer progression in men with prostate cancer (PCa) owing to their abundance and androgenic potential. We hypothesized that preoperative circula...
- 1 February 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 209 (2) , 337-346
Open AccessPreoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer
Purpose:Adrenal 11-oxygenated androgens may support cancer progression in men with prostate cancer (PCa) owing to their abundance and androgenic potential. We hypothesized that preoperative circula...
- Open Access
- 1 December 2022
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 208 (6) , 1214-1225
Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level
Dihydrotestosterone and testosterone are thought to be major contributors of prostate cancer progression and resistance. We studied the modulation of 15 circulating steroids by castration and their association with dihydrotestosterone and testosterone levels. A total of 116 serum samples were collected from 99 prostate cancer patients and categorized as eugonadal, castration-sensitive prostate cancer, castration-resistant prostate cancer, or castration-resistant prostate cancer under abiraterone acetate. Serum levels of 15 steroids were measured using mass spectrometry and compared between groups using analysis of variance. Intrapatient association of steroid levels and the androgens testosterone and dihydrotestosterone were assessed using Pearson correlation and linear regression. Testosterone, dihydrotestosterone, androstenedione, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, androsterone, androstenediol, estrone, estrone-sulfate, estradiol, and androsterone/3α-diol-3/3α-diol-17-glucuronide levels were significantly decreased in castration-sensitive prostate cancer (castrated) compared to eugonadal patients. Testosterone levels were strongly associated with multiple steroids under eugonadal conditions, whereas they were weakly affected by precursor steroids in castrated patients. By contrast, dihydrotestosterone levels under androgen deprivation therapy were associated with testosterone and the backdoor pathway metabolite androsterone. In castration-resistant prostate cancer patients, levels of androstenedione were significantly associated with testosterone level, while testosterone was the only steroid associated with dihydrotestosterone levels. Androgen deprivation therapy significantly reduces the levels of 13 circulating steroids. Upon androgen deprivation therapy initiation, the backdoor pathway metabolite androsterone are strongly associated with dihydrotestosterone levels. Under castration-resistant prostate cancer conditions, androstenedione was significantly associated with testosterone levels, suggesting the presence of tumor-related circulating androgens in these patients. These results provide further rationale to intensify treatments with androgen receptor axis signaling pathway inhibitors in patients with prostate cancer.
- 1 December 2022
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 208 (6) , 1214-1225
Open AccessExtensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level
Dihydrotestosterone and testosterone are thought to be major contributors of prostate cancer progression and resistance. We studied the modulation of 15 circulating steroids by castration and their association with dihydrotestosterone and testosterone levels. A total of 116 serum samples were collected from 99 prostate cancer patients and categorized as eugonadal, castration-sensitive prostate cancer, castration-resistant prostate cancer, or castration-resistant prostate cancer under abiraterone acetate. Serum levels of 15 steroids were measured using mass spectrometry and compared between groups using analysis of variance. Intrapatient association of steroid levels and the androgens testosterone and dihydrotestosterone were assessed using Pearson correlation and linear regression. Testosterone, dihydrotestosterone, androstenedione, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, androsterone, androstenediol, estrone, estrone-sulfate, estradiol, and androsterone/3α-diol-3/3α-diol-17-glucuronide levels were significantly decreased in castration-sensitive prostate cancer (castrated) compared to eugonadal patients. Testosterone levels were strongly associated with multiple steroids under eugonadal conditions, whereas they were weakly affected by precursor steroids in castrated patients. By contrast, dihydrotestosterone levels under androgen deprivation therapy were associated with testosterone and the backdoor pathway metabolite androsterone. In castration-resistant prostate cancer patients, levels of androstenedione were significantly associated with testosterone level, while testosterone was the only steroid associated with dihydrotestosterone levels. Androgen deprivation therapy significantly reduces the levels of 13 circulating steroids. Upon androgen deprivation therapy initiation, the backdoor pathway metabolite androsterone are strongly associated with dihydrotestosterone levels. Under castration-resistant prostate cancer conditions, androstenedione was significantly associated with testosterone levels, suggesting the presence of tumor-related circulating androgens in these patients. These results provide further rationale to intensify treatments with androgen receptor axis signaling pathway inhibitors in patients with prostate cancer.